intestinal bacterial overgrowth

intestinal bacterial overgrowth

Afferent loop syndrome, gastrojejunal loop obstruction, stagnant loop syndrome Infectious disease A condition characterized by excess growth of opportunistic bacteria, which occurs when normal gut flora is eradicated with antibiotics Clinical Necrotizing enterocolitis, pseudomembranous colitis. See Pseudomembranous colitis.
References in periodicals archive ?
Many things can cause bloating -- lactose intolerance, celiac disease, small intestinal bacterial overgrowth, infection or other conditions, said Samantha Heller, a senior clinical nutritionist at New York University Langone Health.
As a proof-of-concept, this system has been designed to aid in the diagnosis and monitoring of small intestinal bacterial overgrowth. The system has three components: a capsule, a wearable receiver, and analysis software.
Proton pump inhibitor use and the risk of small intestinal bacterial overgrowth: a meta-analysis.
Association between small intestinal bacterial overgrowth and toll-like receptor 4 in patients with pancreatic carcinoma and cholangiocarcinoma
Aerodiagnostics, a laboratory that specialises in hydrogen and methane breath testing for small intestinal bacterial overgrowth (SIBO) and lactose, fructose and sucrose intolerances, announced on Friday that it has appointed Dr Kathleen O'Neil-Smith as its incoming Medical Director, succeeding the company's outgoing Laboratory Director, Dr Lisa Cohen.
Probiotic yogurt in the elderly with intestinal bacterial overgrowth: endotoxaemia and innate immune functions.
Lee et al., "Association between small intestinal bacterial overgrowth and peripheral bacterial DNA in cirrhotic patients," Digestive Diseases and Sciences, vol.
As a result of a large volume of partially digested nutrients, the presence of thick glycoprotein-rich mucus changes the components of the intestinal flora, and due to abnormalities of gut motility, small intestinal bacterial overgrowth (SIBO) often develops.
Small intestinal bacterial overgrowth (SIBO), increased intestinal permeability, and a number of bacterial endotoxins were reported as putative factors for NASH development [18].
The pathophysiology of IBS is not well understood; however, many recent studies suggest that altered gut microbiota such as small intestinal bacterial overgrowth (SIBO) and intestinal microinflammation play an important role [2, 3].